TB-500 is a synthetic version of a naturally occurring peptide fragment of thymosin beta-4, studied for its potential to support cellular migration and tissue recovery. Research has focused on its role in actin regulation and angiogenesis within experimental settings. It is also examined for its potential in wound and soft tissue models.